Article

Selected Ideal Natural Ligand Against TNBC by Inhibiting CDC20, Using Bioinformatics and Molecular Biology

2021-08-10

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Triple-negative breast cancer (TNBC), as the most aggressive kinds of breast tumor, still cannot get effective targeted therapy. Recently, techniques of bioinformatics and molecular biology were hot topics in drug development. We want to find potential therapeutic targets of triple-negative breast cancer (TNBC) patients by bioinformatics and screen ideal natural...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: aa8210a9-3ee6-5e74-b7b7-9533f1b9e60c
DOI: 10.21203/rs.3.rs-770130/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Selected Ideal Natural Ligand Against TNBC by Inhibiting CDC20, Using Bioinformatics and Molecular BiologyDOI 10.21203/rs.3.rs-770130/v1Read

Identifying critical genes of breast cancer and corresponding leading compounds of potential therapeutic targetsSemantic proximity Read

Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatmentSemantic proximity Read

Screening and identification of phytochemical drug molecules against mutant BRCA1 receptor of breast cancer using computational approaches.Semantic proximity Read

Cyclin-Dependent Kinase Inhibitors Function as Potential Immune Regulators via Inducing Pyroptosis in Triple Negative Breast CancerSemantic proximity Read

Molecular docking and MD simulation approach to identify potential phytochemical lead molecule against triple negative breast cancerSemantic proximity Read

The potential mechanism of pachymic acid in triple-negative breast cancer: a network pharmacology and vitro experimentsSemantic proximity Read

Prognostic and Therapeutic Implications of Cell Division Cycle 20 Homolog in Breast CancerSemantic proximity Read

Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancerSemantic proximity Read

Novel natural inhibitors targeting KRAS G12C by computational study.Semantic proximity Read

New Natural Compound Inhibitors of Checkpoint Kinase-1(CHK1) Based on Computational StudySemantic proximity Read

Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancerSemantic proximity Read

A systems biology-based study to assess the effects of TNF-α ± apigenin in triple-negative breast cancer cell lineSemantic proximity Read